How effective is chemotherapy for HER2-positive breast cancer?

HER2-positive cells carry larger amounts of the HER2 protein, which can encourage growth. Chemotherapy attacks rapidly dividing cells throughout the body, while HER2-targeted medicine is designed to interfere with that specific growth signal. Treatment may be given before surgery to shrink the tumour and show how it responds, after surgery to treat possible microscopic disease, or for advanced cancer to slow growth and relieve symptoms. The word effective does not mean the same outcome for everyone. Doctors judge benefit using the tumour’s size, lymph-node findings, biology, response during treatment, and whether cancer is present elsewhere.

Discuss the full sequence: chemotherapy, HER2-targeted medicine, surgery, radiotherapy, and hormone treatment when relevant. Your team may check heart function before and during some HER2-directed medicines, and blood tests help guide chemotherapy timing and dosing. Tell the team about heart conditions, other medicines, pregnancy plans, numbness, or prior treatment. Plan support for meals, transport, rest, and infection precautions. Do not stop treatment or supplements without checking with the oncology team.

Call promptly for fever or chills, new shortness of breath, chest discomfort, fainting, a racing or irregular heartbeat, persistent vomiting, or inability to drink. Report swelling, sudden weight change, severe diarrhoea, bleeding, or worsening weakness. A new breast or chest symptom should be discussed with the team, while breathing or heart symptoms require urgent assessment.

What benefit is expected from adding chemotherapy to HER2-targeted treatment in my situation? Is treatment before surgery appropriate, and how will response change the next step? How will my heart function and other side effects be monitored?